Table 2 Main clinical outcomes

From: Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway

 

Control group (n = 6)

Lobeline group (n = 10)

Between-group difference (95% CI)

p value

Ventilator-free days at 28 days

2.83 (3.04)

8.3 (9.06)

−5.47% (−10.58 to −0.36)

0.037a

ICU survival rate

1 (16.67%)

8 (80%)

−0.63% (−0.25 to −1.02)

0.035a

Hospital survival rate

1 (16.67%)

4 (40%)

−0.24% (−0.66 to 0.19)

0.588

  1. Data are n (%), mean (SD), or median with between-group difference (95% CI). To compare categorical variables, Fisher’s exact test was used
  2. ICU intensive care unit
  3. aCalculated for survival rate